BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Nam HS. Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide. J Stroke 2019;21:151-9. [PMID: 31161760 DOI: 10.5853/jos.2019.00472] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 8.7] [Reference Citation Analysis]
Number Citing Articles
1 Li C, Zhu L, Dai Y, Zhang Z, Huang L, Wang TJ, Fu P, Li Y, Wang J, Jiang C, Atochin DN. Diet-Induced High Serum Levels of Trimethylamine-N-oxide Enhance the Cellular Inflammatory Response without Exacerbating Acute Intracerebral Hemorrhage Injury in Mice. Oxidative Medicine and Cellular Longevity 2022;2022:1-16. [DOI: 10.1155/2022/1599747] [Reference Citation Analysis]
2 Synoradzki K, Grieb P. Citicoline: A Superior Form of Choline? Nutrients 2019;11:E1569. [PMID: 31336819 DOI: 10.3390/nu11071569] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
3 Zhang J, Tang Q, Zhu L. Could the Gut Microbiota Serve as a Therapeutic Target in Ischemic Stroke? Evid Based Complement Alternat Med 2021;2021:1391384. [PMID: 33959182 DOI: 10.1155/2021/1391384] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, Scicchitano M, Oppedisano F, Bosco F, Ruga S, Zito MC, Macri R, Palma E, Muscoli C, Mollace V. The Contribution of Gut Microbiota-Brain Axis in the Development of Brain Disorders. Front Neurosci 2021;15:616883. [PMID: 33833660 DOI: 10.3389/fnins.2021.616883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
5 Zhang XN, Yu ZL, Chen JY, Li XY, Wang ZP, Wu M, Liu LT. The crosstalk between NLRP3 inflammasome and gut microbiome in atherosclerosis. Pharmacol Res 2022;:106289. [PMID: 35671922 DOI: 10.1016/j.phrs.2022.106289] [Reference Citation Analysis]
6 Tan C, Wang H, Gao X, Xu R, Zeng X, Cui Z, Zhu J, Wu Q, Xia G, Zhou H, He Y, Yin J. Dynamic Changes and Prognostic Value of Gut Microbiota-Dependent Trimethylamine-N-Oxide in Acute Ischemic Stroke. Front Neurol 2020;11:29. [PMID: 32082246 DOI: 10.3389/fneur.2020.00029] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
7 Chung SJ, Rim JH, Ji D, Lee S, Yoo HS, Jung JH, Baik K, Choi Y, Ye BS, Sohn YH, Yun M, Lee SG, Lee PH. Gut microbiota-derived metabolite trimethylamine N-oxide as a biomarker in early Parkinson's disease. Nutrition 2021;83:111090. [PMID: 33418492 DOI: 10.1016/j.nut.2020.111090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhang WQ, Wang YJ, Zhang A, Ding YJ, Zhang XN, Jia QJ, Zhu YP, Li YY, Lv SC, Zhang JP. TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies. J Cardiovasc Transl Res 2021. [PMID: 33709384 DOI: 10.1007/s12265-021-10115-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Farhangi MA, Vajdi M, Asghari-Jafarabadi M. Gut microbiota-associated metabolite trimethylamine N-Oxide and the risk of stroke: a systematic review and dose-response meta-analysis. Nutr J 2020;19:76. [PMID: 32731904 DOI: 10.1186/s12937-020-00592-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
10 Prame Kumar K, Wong CH. Imbalance in the force: the dark side of the microbiota on stroke risk and progression. Curr Opin Neurobiol 2020;62:10-6. [PMID: 31809996 DOI: 10.1016/j.conb.2019.10.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
11 Lee G, Choi S, Chang J, Choi D, Son JS, Kim K, Kim SM, Jeong S, Park SM. Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Netw Open 2021;4:e2136008. [PMID: 34817582 DOI: 10.1001/jamanetworkopen.2021.36008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 [DOI: 10.1109/apwimob51111.2021.9435205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu Z, Lu D, Yuan J, Ren M, Ma R, Xie Q, Li Y, Li J, Wang J. Storax, A Promising Botanical Medicine for Treating Cardio-Cerebrovascular Diseases: A Review. Front Pharmacol 2021;12:785598. [PMID: 34916951 DOI: 10.3389/fphar.2021.785598] [Reference Citation Analysis]
14 Annunziata G, Ciampaglia R, Capò X, Guerra F, Sureda A, Tenore GC, Novellino E. Polycystic ovary syndrome and cardiovascular risk. Could trimethylamine N-oxide (TMAO) be a major player? A potential upgrade forward in the DOGMA theory. Biomed Pharmacother 2021;143:112171. [PMID: 34536755 DOI: 10.1016/j.biopha.2021.112171] [Reference Citation Analysis]
15 Rox K, Rath S, Pieper DH, Vital M, Brönstrup M. A simplified LC-MS/MS method for the quantification of the cardiovascular disease biomarker trimethylamine-N-oxide and its precursors. J Pharm Anal 2021;11:523-8. [PMID: 34513129 DOI: 10.1016/j.jpha.2021.03.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Schneider C, Okun JG, Schwarz KV, Hauke J, Zorn M, Nürnberg C, Ungerer M, Ringleb PA, Mundiyanapurath S. Trimethylamine-N-oxide is elevated in the acute phase after ischaemic stroke and decreases within the first days. Eur J Neurol 2020;27:1596-603. [PMID: 32282978 DOI: 10.1111/ene.14253] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
17 Battaglini D, Robba C, Lopes da Silva A, Dos Santos Samary C, Leme Silva P, Dal Pizzol F, Pelosi P, Rocco PRM. Brain-heart interaction after acute ischemic stroke. Crit Care 2020;24:163. [PMID: 32317013 DOI: 10.1186/s13054-020-02885-8] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
18 Lee YT, Mohd Ismail NI, Wei LK. Microbiome and ischemic stroke: A systematic review. PLoS One 2021;16:e0245038. [PMID: 33439913 DOI: 10.1371/journal.pone.0245038] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
19 Huang Q, Cai G, Liu T, Liu Z. Relationships Among Gut Microbiota, Ischemic Stroke and Its Risk Factors: Based on Research Evidence. IJGM 2022;Volume 15:2003-23. [DOI: 10.2147/ijgm.s353276] [Reference Citation Analysis]
20 Zhu B, Zhai Y, Ji M, Wei Y, Wu J, Xue W, Tao WW, Wu H. Alisma orientalis Beverage Treats Atherosclerosis by Regulating Gut Microbiota in ApoE-/- Mice. Front Pharmacol 2020;11:570555. [PMID: 33101028 DOI: 10.3389/fphar.2020.570555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Pluta R, Januszewski S, Czuczwar SJ. The Role of Gut Microbiota in an Ischemic Stroke. Int J Mol Sci 2021;22:E915. [PMID: 33477609 DOI: 10.3390/ijms22020915] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Sharma V, Sharma V, Shahjouei S, Li J, Chaudhary D, Khan A, Wolk DM, Zand R, Abedi V. At the Intersection of Gut Microbiome and Stroke: A Systematic Review of the Literature. Front Neurol 2021;12:729399. [PMID: 34630304 DOI: 10.3389/fneur.2021.729399] [Reference Citation Analysis]
23 Sun T, Zhang Y, Yin J, Peng X, Zhou L, Huang S, Wen Y, Cao B, Chen L, Li X, Yang W, Tan A, Cheng J, Liu L. Association of Gut Microbiota-Dependent Metabolite Trimethylamine N-Oxide with First Ischemic Stroke. J Atheroscler Thromb 2021;28:320-8. [PMID: 32641646 DOI: 10.5551/jat.55962] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
24 He N, Shen G, Jin X, Li H, Wang J, Xu L, Chen J, Cao X, Fu C, Shi D, Song X, Liu S, Li Y, Zhao T, Li J, Zhong J, Shen Y, Zheng M, Chen Y, Wang L. Resveratrol suppressed microglia activation and promoted functional recovery of traumatic spinal cord via improving intestinal microbiota. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106377] [Reference Citation Analysis]
25 He S, Jiang H, Zhuo C, Jiang W. Trimethylamine/Trimethylamine-N-Oxide as a Key Between Diet and Cardiovascular Diseases. Cardiovasc Toxicol 2021;21:593-604. [PMID: 34003426 DOI: 10.1007/s12012-021-09656-z] [Reference Citation Analysis]
26 Feng W, Liu J, Cheng H, Zhang D, Tan Y, Peng C. Dietary compounds in modulation of gut microbiota-derived metabolites. Front Nutr 2022;9:939571. [DOI: 10.3389/fnut.2022.939571] [Reference Citation Analysis]
27 Gao Q, Wang Y, Wang X, Fu S, Zhang X, Wang RT, Zhang X. Decreased levels of circulating trimethylamine N-oxide alleviate cognitive and pathological deterioration in transgenic mice: a potential therapeutic approach for Alzheimer's disease. Aging (Albany NY) 2019;11:8642-63. [PMID: 31612864 DOI: 10.18632/aging.102352] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
28 Zhao J, Liu S, Yan J, Zhu X. The Impact of Gut Microbiota on Post-Stroke Management. Front Cell Infect Microbiol 2021;11:724376. [PMID: 34712621 DOI: 10.3389/fcimb.2021.724376] [Reference Citation Analysis]
29 Ferreira EP, Acosta-Navarro JC, Antoniazzi L. Why Not Talk about the Harms of Meat Consumption? Adv Nutr 2020;11:736. [PMID: 32419016 DOI: 10.1093/advances/nmz124] [Reference Citation Analysis]
30 Su H, Fan S, Zhang L, Qi H. TMAO Aggregates Neurological Damage Following Ischemic Stroke by Promoting Reactive Astrocytosis and Glial Scar Formation via the Smurf2/ALK5 Axis. Front Cell Neurosci 2021;15:569424. [PMID: 33815059 DOI: 10.3389/fncel.2021.569424] [Reference Citation Analysis]
31 Chang Y, Woo HG, Jeong JH, Kim GH, Park KD, Song TJ. Microbiota dysbiosis and functional outcome in acute ischemic stroke patients. Sci Rep 2021;11:10977. [PMID: 34040060 DOI: 10.1038/s41598-021-90463-5] [Reference Citation Analysis]
32 Gallego-Fabrega C, Muiño E, Cárcel-Márquez J, Llucià-Carol L, Lledós M, Martín-Campos JM, Cullell N, Fernández-Cadenas I. Genome-Wide Studies in Ischaemic Stroke: Are Genetics Only Useful for Finding Genes? Int J Mol Sci 2022;23:6840. [PMID: 35743317 DOI: 10.3390/ijms23126840] [Reference Citation Analysis]
33 Fang Z, Chen M, Qian J, Wang C, Zhang J. The Bridge Between Ischemic Stroke and Gut Microbes: Short-Chain Fatty Acids. Cell Mol Neurobiol. [DOI: 10.1007/s10571-022-01209-4] [Reference Citation Analysis]
34 Chen P, Guo Z. Plasmatic trimethylamine N-oxide and its relation to stroke: A systematic review and dose-response meta-analysis. Medicine (Baltimore) 2022;101:e29512. [PMID: 35866835 DOI: 10.1097/MD.0000000000029512] [Reference Citation Analysis]
35 Koszewicz M, Jaroch J, Brzecka A, Ejma M, Budrewicz S, Mikhaleva LM, Muresanu C, Schield P, Somasundaram SG, Kirkland CE, Avila-Rodriguez M, Aliev G. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment. Pharmacol Res 2021;164:105277. [PMID: 33166735 DOI: 10.1016/j.phrs.2020.105277] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]